Geographic Access to Acute Stroke Care in the United States

BACKGROUND AND PURPOSE: Only 3% to 5% of patients with acute ischemic stroke receive intravenous recombinant tissue-type plasminogen activator (r-tPA) and <1% receive endovascular therapy. We describe access of the US population to all facilities that actually provide intravenous r-tPA or endovas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Stroke
Autores principales: Adeoye, Opeolu, Albright, Karen C., Carr, Brendan G., Wolff, Catherine, Mullen, Micheal T., Abruzzo, Todd, Ringer, Andrew, Khatri, Pooja, Branas, Charles, Kleindorfer, Dawn
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5877807/
https://ncbi.nlm.nih.gov/pubmed/25158773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.114.006293
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares